Clinical Trials Browser

Interventional × Cytokine Release Syndrome × tocilizumab × Clear all

NCT05972135 2026-02-23

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Multiple Myeloma

NCT04394182 2022-03-29

ULTRA-COVID

Phase NA Suspended

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome